https://www.avient.com/sites/default/files/2024-08/Avient AUG 2024 Investor Presentation- w Non-GAAP.pdf
&
Canada
EMEA
Asia
Latin America
64%
36%
Specialty
Engineered
Materials
Color
Additives
and Inks
41%
36%
18%
5%
7%
7%
23%
19%
9%
16%
10%
5% 4%
Defense
Healthcare
Packaging
Consumer
Building &
Construction
Industrial
Transportation
Energy Telecom
Geography
Segment
Industry
2024 Financial Guidance
$515 to $540 million
Adjusted EBITDA
$2.55 to $2.70
Adjusted EPS
4
Industry Sustainability Standards
ESG Ratings Performance
1
2
4
87th
94th
percentile
Avient CDP Score:
A-
SUSTAINABILITY PERFORMANCE
AND RECOGNITION
A U G U S T 6 , 2 0 2 4
W E B C A S T
P R E S E N TA T I O N
6
Q2 2024 HIGHLIGHTS
• 5% organic sales growth supported by
broad-based growth across all regions
in both CAI and SEM segments
• Growth stemmed from gaining share,
winning new product specifications
and restocking in certain end markets
• Cost control and operational
discipline expanded EBITDA margins
by 100 bps
• EPS exceeded guidance by $0.05
and increased 21% vs the prior year
Adj.
Q2 2023
( T O TA L C O M PA N Y )
$824
$850
Q2 23 Q2 24
$131
$143
Q2 23 Q2 24
Sales Adjusted EBITDA
(in millions)
$0.63
$0.76
Q2 23 Q2 24
(in millions)
Adjusted EBITDA Adjusted EPS
8
+ 3%
(+5% excluding FX)
+ 9%
(+12% excluding FX)
+ 21%
(+25% excluding FX)
Sales
9
Q2 2 024 RESULTS – ORGA NI C SA LES BY
REGION VS PY
9
US & Canada
Latin America
EMEA
Asia
+5%
+4%
+1%
+19%
Avient ex.
Three Months Ended
June 30,
2024 2023
Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS
Net income from continuing operations attributable to Avient shareholders $ 33.6 $ 0.36 $ 22.1 $ 0.24
Special items, after-tax 21.8 0.24 19.6 0.21
Amortization expense, after-tax 14.8 0.16 16.2 0.18
Adjusted net income / EPS $ 70.2 $ 0.76 $ 57.9 $ 0.63
Three Months Ended
June 30,
Reconciliation to EBITDA and Adjusted EBITDA: 2024 2023
Net income from continuing operations – GAAP $ 33.8 $ 22.3
Income tax expense 11.2 10.4
Interest expense, net 26.6 29.4
Depreciation & amortization 44.9 47.6
EBITDA from continuing operations $ 116.5 $ 109.7
Special items, before tax 28.1 21.7
Interest expense included in special items (1.0) —
Depreciation & amortization included in special items (0.3) (0.1)
Adjusted EBITDA $ 143.3 $ 131.3
Adjusted EBITDA as a percent of sales 16.9 % 15.9 %
1
Three Months Ended
June 30,
2024 2023
Sales:
Color, Additives and Inks $ 542.0 $ 524.5
Specialty Engineered Materials 308.1 300.8
Corporate (0.4) (0.9)
Sales $ 849.7 $ 824.4
Operating income:
Color, Additives and Inks $ 86.1 $ 68.0
Specialty Engineered Materials 42.8 39.7
Corporate (56.4) (45.4)
Operating income $ 72.5 $ 62.3
Depreciation & amortization:
Color, Additives and Inks $ 21.8 $ 25.7
Specialty Engineered Materials 20.8 19.9
Corporate 2.3 2.0
Depreciation & amortization $ 44.9 $ 47.6
Earnings before interest, taxes, depreciation and amortization (EBITDA):
Color, Additives and Inks $ 107.9 $ 93.7
Specialty Engineered Materials 63.6 59.6
Corporate (54.1) (43.4)
Other expense, net (0.9) (0.2)
EBITDA from continuing operations 116.5 109.7
Special items, before tax 28.1 21.7
Interest expense included in special items (1.0) —
Depreciation & amortization included in special items (0.3) (0.1)
Adjusted EBITDA $ 143.3 $ 131.3
Adjusted EBITDA as a percent of sales:
Color, Additives and Inks 19.9 % 17.9 %
Specialty Engineered Materials 20.6 % 19.8 %
2
Year Ended
December 31, 2023
Reconciliation to Condensed Consolidated Statements of Income $ EPS
Net income from continuing operations attributable to Avient shareholders $ 75.8 $ 0.83
Special items, after-tax 79.3 0.86
Amortization expense, after-tax 61.5 0.67
Adjusted net income / EPS $ 216.6 $ 2.36
Adjusted Free Cash Flow Calculation December 31, 2023
Cash provided by operating activities $ 201.6
Capital expenditures (119.4)
Free cash flow 82.2
Taxes paid on gain on sale of business 104.1
Adjusted free cash flow $ 186.3
Year Ended
December 31, 2023
Sales:
Color, Additives and Inks $ 2,007.4
Specialty Engineered Materials 1,138.2
Corporate (2.8)
Sales $ 3,142.8
Operating income:
Color, Additives and Inks $ 259.9
Specialty Engineered Materials 142.5
Corporate (205.6)
Operating income $ 196.8
Depreciation & amortization:
Color, Additives and Inks $ 98.3
Specialty Engineered Materials 81.5
Corporate 9.0
Depreciation & amortization $ 188.8
Earnings before interest, taxes, depreciation and amortization (EBITDA):
Color, Additives and Inks $ 358.2
Specialty Engineered Materials 224.0
Corporate (196.6)
Other income, net 5.8
EBITDA from continuing operations 391.4
Special items, before tax 114.6
Interest expense included in special items (2.3)
Depreciation & amortization included in special items (1.9)
Adjusted EBITDA $ 501.8
Adjusted EBITDA as a percent of sales 16.0 %
3
AVNT M8 Investor Presentation.pdf
Avient Disclaimer SLide.pdf
AVNT M8 Investor Presentation
IR Deck - AVNT-2024.06.30 (M8) (8.26.24 11AM Milestone August 26 1053 am).pdf
Attachment
https://www.avient.com/sites/default/files/2023-10/ISO13485 -2016 - 2021.2.20~2024.2.19 -EN.pdf
5‘冲」之七乃竿月 rf』J枯:“号淤,石
「3
;:;This certificate is valid from 20 February 2021 until 19 February 2024
S
SGSGS and remains valid subject to satisfactory surveillance audits
Re certification audit due before 6 January 2024
Issue 6.
Certified since 19 February 2009
GSCS6S&SSSGSG SGS
GSGSGSGSGSCSf
g r
I
's
r
I!
https://www.avient.com/news/avient-site-taiwan-earns-iso-13485-accreditation-fourth-source-mevopur-medical-grade-materials
January 19, 2022
TAOYUAN, Taiwan – January 19, 2022 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, today announced the ISO 13485:2016 certification of its production site in Taoyuan, Taiwan (near Taipei).
https://www.avient.com/news/‘future-proof’-pharma-packaging-avient-launches-new-regulatory-compliant-mevopur-amber-masterbatches
April 19, 2021
CLEVELAND – April 19, 2021 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, today announced the launch of a new pelletized amber colorant masterbatch formulated for PET vials, bottles, and other pharmaceutical packaging applications.